Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Dietary fish oil containing ω3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), elicit cardioprotective and anti-inflammatory effects through unresolved mechanisms that may involve competition and inhibition at multiple levels. Here, we report the effects of arachidonic acid (AA), EPA, and DHA supplementation on membrane incorporation, phospholipase A(2) catalyzed release, and eicosanoid production in RAW264.7 macrophages. Using a targeted lipidomics approach, we observed that Toll-like receptor 4 and purinergic receptor activation of supplemented cells leads to the release of 22-carbon fatty acids that potently inhibit cyclooxygenase pathways. This inhibition was able to shunt metabolism of AA to lipoxygenase pathways, augmenting leukotriene and other lipoxygenase mediator synthesis. In resident peritoneal macrophages, docosapentaenoic acid (DPA) was responsible for cyclooxygenase inhibition after EPA supplementation, offering fresh insights into how EPA exerts anti-inflammatory effects indirectly through elongation to 22-carbon DPA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is now also known that DPA also produces analogous inflammatory mediators to EPA and DHA, and elongation of EPA to DPA may be an important event in the inhibition of the COX pathway [52,146].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [52]
Citations
Cites
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932 · cited 1×
“In activated macrophages, there is a significant capacity for metabolism of EPA and DHA through 5LOX, which helps to explain how resolvins can form in vivo (41).”
BackgroundDennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V., & Kokotos, G. (2011) · Chemical Reviews · doi:10.1021/cr200085w · Cited by 1,203 · cited 1×
“AA is a C20:4 fatty acid that is mostly esterified at the sn-2 position of membrane phospholipids in resting cells, but can be released by phospholipase A2 (PLA2) (5, 6) after various stimuli.”
BackgroundSelf-citationPhosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling
Kagan, J. C., & Medzhitov, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.047 · Cited by 847
The composition of the Eskimo food in north western Greenland.
Bang, H. O., Dyerberg, J., & Sinclair, H. M. (1980) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.12.2657 · Cited by 807 · cited 3×
“Balboa MA, Balsinde J, Johnson CA, Dennis EA (1999) Regulation of arachidonic acid mobilization in lipopolysaccharide-activated P388D(1) macrophages by adenosine triphosphate.”
BackgroundInfluentialNucleotide receptors: an emerging family of regulatory molecules in blood cells
Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J. M., Morelli, A., Torboli, M., Bolognesi, G., & Baricordi, O. R. (2001) · Blood · doi:10.1182/blood.v97.3.587 · Cited by 703 · cited 1×
“Of all purinergic receptors (P2X and P2Y), only P2X7 requires 2 mM ATP for activation (14, 15).”
Backgroundn–3 Fatty Acids in Cardiovascular Disease
De Caterina, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1008153 · Cited by 568
Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology
Buczynski, M. W., Dumlao, D. S., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900004-jlr200 · Cited by 530
Self-citationDocosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis.
Corey, E. J., Shih, C., & Cashman, J. R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3581 · Cited by 419 · cited 4×
“DHA is known to be a potent inhibitor of AA prostaglandin production (9).”
BackgroundInfluentialWada, M., DeLong, C. J., Hong, Y. H., Rieke, C. J., Song, I., Sidhu, R. S., Yuan, C., Warnock, M., Schmaier, A. H., Yokoyama, C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703169200 · Cited by 400 · cited 18×
“WB WB Co nt ro l Co nt ro l A A EP A D H A EP A A A D H A Rep. 1 Rep. 2 8 Hr KLA COX-2 GAPDH6 ce lls ) 0 30 60 90 120 0 4 8 12 16 20 24 PGE2 Ei co sa no id ( pm ol /1 0 0 10 20 30 40 50 0 4 8 12 16 20 24 HETE11- 0 1 2 3 4 0 4 8 12 16 20 24 PGD3 Time (Hr) 0 0.2 0.4 0.6 0.8 1 0 4 8 12 16 20 24 2Dihomo PGD Control AA EPA…”
BackgroundInfluentialMolecular physiology of p2x receptors and atp signalling at synapses
Khakh, B. S. (2001) · Nature Reviews Neuroscience · doi:10.1038/35058521 · Cited by 363 · cited 1×
“Of all purinergic receptors (P2X and P2Y), only P2X7 requires 2 mM ATP for activation (14, 15).”
BackgroundBalsinde, J., Bianco, I. D., Ackermann, E. J., Conde-Frieboes, K., & Dennis, E. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8527 · Cited by 287 · cited 1×
“Turnover and incorporation of PUFAs in resting macrophages has been shown to be highly dependent on the constitutively expressed Ca-independent iPLA2 by hydrolyzing fatty acids at the sn-2 position of phospholipids to generate lysophospholipids, allowing PUFA esterification by a CoA-dependent acyltransferase (25).”
BackgroundSelf-citationStructure, function and regulation of Ca2+‐sensitive cytosolic phospholipase A2 (cPLA2)
Kramer, R. M., & Sharp, J. D. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00322-0 · Cited by 253 · cited 1×
“With P2X7 stimulation, cPLA2 is translocated to the membrane in a Ca dependent manor, where AA and EPA appear to be equally good substrates, and DHA is essentially not released after activation (29, 30).”
BackgroundApplications of Mass Spectrometry to Lipids and Membranes
Harkewicz, R., & Dennis, E. A. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060409-092612 · Cited by 210 · cited 1×
“Using a combination of GC-MS and LC-MS/MS analysis (11), we have been able to accurately quantify PUFA phospholipid incorporation and release and relate this to the quantities and identities of nearly all AA-derived eicosanoids and key EPA- and DHA-derived eicosanoids produced.”
MethodSelf-citationIdentification and expression of mammalian long‐chain PUFA elongation enzymes
Leonard, A. E., Kelder, B., Bobik, E. G., Chuang, L., Lewis, C. J., Kopchick, J. J., Mukerji, P., & Huang, Y. (2002) · Lipids · doi:10.1007/s11745-002-0955-6 · Cited by 209
Effect of ω-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer
Anti, M., Marra, G., Armelao, F., Bartoli, G. M., Ficarelli, R., Percesepe, A., De Vitis, I., Maria, G., Sofo, L., Rapaccini, G. L., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90021-p · Cited by 204
Peters-Golden, M., & Brock, T. G. (2003) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00070-x · Cited by 197 · cited 1×
“In this intracellular Ca mobilizing condition, 5-LOX is translocated to the membrane and can act on released PUFAs with the assistance of 5-LOX activating protein (23), concomitantly with constitutive COX-1.”
BackgroundMosior, M., Six, D. A., & Dennis, E. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2184 · Cited by 178
Self-citationLands, W. E. M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00177-8 · Cited by 172 · cited 1×
“Analysis of cell membrane composition established that supplemented ω3 PUFAs and their elongated analogs could be incorporated into membrane phospholipids, presumably at the sn-2 position, at a significant level consistent with traditional phospholipid remodeling (13).”
BackgroundResolvin E1 protects the rat heart against reperfusion injury
Keyes, K. T., Ye, Y., Lin, Y., Zhang, C., Perez-Polo, J. R., Gjorstrup, P., & Birnbaum, Y. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01057.2009 · Cited by 168 · cited 1×
“Although DHA is generally considered to be cardioprotective after membrane incorporation via mechanisms that improve receptor and ion channel function, EPA can also be metabolized to resolvin E1, which has recently been demonstrated to have potent cardioprotective action (10).”
BackgroundHuman Microsomal Prostaglandin E Synthase-1
Thorén, S., Weinander, R., Saha, S., Jegerschöld, C., Pettersson, P. L., Samuelsson, B., Hebert, H., Hamberg, M., Morgenstern, R., & Jakobsson, P.-J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303227200 · Cited by 167
Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein
Agbaga, M.-P., Mandal, M. N. A., & Anderson, R. E. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r005025 · Cited by 167 · cited 1×
“At least part of the elongation of AA and EPA in RAW cells is presumably attributed to elongase of very long-chain fatty acids (ELOVL)2 because this enzyme elongates saturated and unsaturated fatty acids between 18 and 22 carbons, and because ELOVL5 does not appear to elongate the 22-carbon fatty acids (27, 28) that w…”
BackgroundHematopoietic prostaglandin D synthase
Kanaoka, Y., & Urade, Y. (2003) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00077-2 · Cited by 159
Conquer, J. A., & Holub, B. J. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33890-6 · Cited by 153
Huwiler, A., Johansen, B., Skarstad, A., & Pfeilschifter, J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0370fje · Cited by 131 · cited 1×
“In this setting, cPLA2 is translocated to the membrane in a Ca-independent fashion by increased membrane affinity and enhanced specific activity that has been linked to generation of PIP2 and conformational changes (5, 31–33), as well as generation of C1P (34), ceramide (35), and diacylglycerol (36).”
BackgroundAKIBA, S., MURATA, T., KITATANI, K., & SATO, T. (2000) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.23.1293 · Cited by 108 · cited 1×
“In fact, DPA is reported to be a more potent COX-1 inhibitor than EPA (38).”
BackgroundShikano, M., Masuzawa, Y., Yazawa, K., Takayama, K., Kudo, I., & Inoue, K. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90255-0 · Cited by 101 · cited 1×
“With P2X7 stimulation, cPLA2 is translocated to the membrane in a Ca dependent manor, where AA and EPA appear to be equally good substrates, and DHA is essentially not released after activation (29, 30).”
BackgroundBuczynski, M. W., Stephens, D. L., Bowers-Gentry, R. C., Grkovich, A., Deems, R. A., & Dennis, E. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701831200 · Cited by 100 · cited 5×
“Because TLR4 stimulation does not lead to changes in intracellular Ca levels, 5LOX is not activated, thus 5-hydroxyeicosatetraenoic acid (HETE) and leukotriene production in RAW cells have not been observed (17, 18).”
BackgroundMethodSelf-citationThe bleeding tendency in Greenland Eskimos.
Bang, H., & Dyerberg, J. (1980) · PubMed · Cited by 90
Rouzer, C. A., Ivanova, P. T., Byrne, M. O., Milne, S. B., Marnett, L. J., & Brown, H. A. (2006) · Biochemistry · doi:10.1021/bi061723j · Cited by 88 · cited 1×
“(26), along with our previous finding that AA supplementation results in de novo elongation of AA to AdA and subsequent dihomo-prostaglandin formation (12), but were surprised that about half of the AA and EPA were elongated.”
BackgroundSpecificity of eicosanoid production depends on the TLR-4-stimulated macrophage phenotype
Norris, P. C., Reichart, D., Dumlao, D. S., Glass, C. K., & Dennis, E. A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311153 · Cited by 85
Self-citationCeramide-1-phosphate activates cytosolic phospholipase A2α directly and by PKC pathway
Nakamura, H., Hirabayashi, T., Shimizu, M., & Murayama, T. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.027 · Cited by 83
Six, D. A., & Dennis, E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301386200 · Cited by 79
Self-citationDangi, B., Obeng, M., Nauroth, J. M., Teymourlouei, M., Needham, M., Raman, K., & Arterburn, L. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809014200 · Cited by 68 · cited 1×
“DPA-derived, resolvin-like anti-inflammatory molecules have also been recently identified (39).”
BackgroundGrkovich, A., Johnson, C. A., Buczynski, M. W., & Dennis, E. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605935200 · Cited by 64
Self-citationn‐3 fatty acids decrease colonic epithelial cell proliferation in high‐risk bowel mucosa
Huang, Y., Jessup, J. M., Forse, R. A., Flickner, S., Pleskow, D., Anastopoulos, H. T., Ritter, V., & Blackburn, G. L. (1996) · Lipids · doi:10.1007/bf02637099 · Cited by 63 · cited 2×
“The overall profiles of AA, EPA, and DHA in phospholipids of control, EPA-, and DHA-supplemented cells closely resembled those of human serum phospholipids before and after EPA and DHA supplementation (4).”
BackgroundResultPinzar, E., Miyano, M., Kanaoka, Y., Urade, Y., & Hayaishi, O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000750200 · Cited by 60
Purification and characterization of recombinant microsomal prostaglandin E synthase-1
Ouellet, M., Falgueyret, J., Ear, P. H., Pen, A., Mancini, J. A., Riendeau, D., & Percival, M. D. (2002) · Protein Expression and Purification · doi:10.1016/s1046-5928(02)00566-1 · Cited by 57 · cited 1×
“Journal Proceedings of the National Academy of Sciences of the United States of America, 109(22)”
BackgroundHarkewicz, R., Fahy, E., Andreyev, A. Y., & Dennis, E. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610067200 · Cited by 51 · cited 2×
“(26), along with our previous finding that AA supplementation results in de novo elongation of AA to AdA and subsequent dihomo-prostaglandin formation (12), but were surprised that about half of the AA and EPA were elongated.”
BackgroundSelf-citationKuwata, H., Fujimoto, C., Yoda, E., Shimbara, S., Nakatani, Y., Hara, S., Murakami, M., & Kudo, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611883200 · Cited by 36
Secretory and cytosolic phospholipases A2 are activated during TNF priming of human neutrophils
Seeds, M. C., Jones, D. F., Chilton, F. H., & Bass, D. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00151-3 · Cited by 36 · cited 1×
“In this setting, cPLA2 is translocated to the membrane in a Ca-independent fashion by increased membrane affinity and enhanced specific activity that has been linked to generation of PIP2 and conformational changes (5, 31–33), as well as generation of C1P (34), ceramide (35), and diacylglycerol (36).”
BackgroundBalboa, M. A., Balsinde, J., Johnson, C. A., & Dennis, E. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36764 · Cited by 33 · cited 1×
“This receptor is expressed and functional in RAW cells, and is reported to be the receptor responsible for the majority of AA release after millimolar ATP stimulation in murine macrophages (16).”
BackgroundSelf-citation
Cited by
Eicosanoid storm in infection and inflammation
Dennis, E. A., & Norris, P. C. (2015) · Nature Reviews Immunology · doi:10.1038/nri3859 · Cited by 1,517
Self-citationPopkin, B. M., Du, S., Green, W. D., Beck, M. A., Algaith, T., Herbst, C. H., Alsukait, R. F., Alluhidan, M., Alazemi, N., & Shekar, M. (2020) · Obesity Reviews · doi:10.1111/obr.13128 · Cited by 1,150
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
“004 with arachidonic acid for eicosanoid biosynthesis, preventing proinflammatory eicosanoids, a process readily discernible in vitro [10].”
BackgroundSignificance of long chain polyunsaturated fatty acids in human health
Zárate, R., el Jaber‐Vazdekis, N., Tejera, N., Pérez, J. A., & Rodríguez, C. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0153-6 · Cited by 551
“Finally, it remains unclear what role sPLA2 may play in eicosanoids signalling, although a cPLA2-dependent increase in the magnitude and duration of free FA levels, including ARA caused by sPLA2 up-regulation has been recently proposed [37, 40].”
BackgroundLayé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
“Also, combination of DHA and NSAIDs should be considered cautiously as it could augment the production of leukotrienes that are proinflammatory, as recently suggested by an elegant in vitro study (Norris and Dennis, 2012).”
Background
Metadata
- Authors
- Norris, P. C., & Dennis, E. A.
- Affiliations
- University of California San Diego (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-05-14
- Volume
- 109
- Issue
- 22
- Pages
- 8517-8522
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3365225
- OpenAlex
- W2048856163
- Cited by
- 193
- References
- 41
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 13 · 2023: 8 · 2022: 12 · 2021: 8 · 2020: 11 · 2019: 9 · 2018: 12 · 2017: 21 · 2016: 14 · 2015: 22 · 2014: 26 · 2013: 20 · 2012: 3
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01 GM 64611, U54GM069338, R01GM064611, T32GM007752)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, docosapentaenoic acid, arachidonic acid, TLR4, eicosanoid signaling, cyclooxygenase inhibition, lipoxygenase pathway, leukotriene biosynthesis, macrophages, fish oil supplementation, anti-inflammatory activity, lipidomics
- MeSH terms
- Adenosine Triphosphate, Animals, Cell Line, Cell Membrane, Cells, Cultured, Docosahexaenoic Acids, Fatty Acids, Unsaturated, Lipopolysaccharides, Lipoxygenase, Macrophages, Male, Gas Chromatography-Mass Spectrometry, Membrane Lipids, Prostaglandin-Endoperoxide Synthases, Blotting, Western, Signal Transduction, Fatty Acids, Omega-3, Eicosanoids, Arachidonic Acid, Macrophages, Peritoneal, Toll-Like Receptor 4, Mice, Phospholipases A2, Receptors, Purinergic P2X7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.